[1] Chen, C.; Li, B.; Yang, D. S.; Jiang, B. Chin. Pharm. Sci. 2016, 25, 779-784.
[2] Yu, J.X.; Jiang, B. Medicine Economic Reporter. 2015-07-27(003).
[3] Chang, F.; Cui, P.L.; Xia, Q.; Zhang, J.Y. Chin. Health Policy Res. 2015, 7, 55-60.
[4] Guo, L.Y.; Men, X.F. Price theory and practice. 2015, 5, 9-12.
[5] Chang, F.; Cui, P.L.; Xia, Q.; Luo, X.Y.; Zhang, J.Y. Chin. J. Pharm. 2015, 8, 915-920.
[6] Yu, J.X.; Jiang, B. Medicine Economic Reporter. 2015-07-13003.
[7] Ding, J.X.; Xue, Y.X.; Li, W.; Zhou, L.; Pan, Y. Chin. Health Insurance. 2016, 7, 9-13.
[8] Acosta, A.; Ciapponi, A.; Aaserud, M.; Vietto, V.; Austvoll-Dahlgren, A.; Koesters, J.; Vacca, C.; Machado, M.; Hazbeydy Diaz Ayala, D.; Oxman, A. Cochrane Library. 2014.
[9] Dylst, P.; Vulto, A.; Simoens, S. Generics Biosimilars Initiative J. 2012, 1, 127-131.
[10] Ding, J.X.; Bai, G.L.; Huang, Z.H.; Liu, P.C.; Li, W. Chin. J. Pharm. 2015, 6, 647-652.
[11] Wu, J.B.; Hao, R.X. Chin. J. Pharma. Tech. Eco. Mana. 2008, 12, 55-57.
[12] Wang, L.B.; Lin, M.; Yang, M.C.; Zhang, Y.M.; Li, B. Chin. Pharm. Aff. 2012, 3, 224-228.
[13] Dong, C.H. Chin. Health Insu. 2015, 7, 21-23, 29.
[14] Wang, D.J. Chin. Health Insu. 2015, 7, 5-8.
[15] Xiong, X.J. Human Resource Dev. 2015, 5, 41-42. |